Wakefield Asset Management’s Merck MRK Stock Holding History

Wakefield Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Hold	8,331	–	–	0.24%	134
2026 Q1	$1M	Hold	8,331	–	–	0.27%	126
2025 Q4	$877K	Sell	8,331 -238	-3%	-$22.3K	0.24%	137
2025 Q3	$719K	Hold	8,569	–	–	0.2%	144
2025 Q2	$678K	Hold	8,569	–	–	0.19%	145
2025 Q1	$769K	Buy	+8,569	New	+$800K	0.23%	136
2023 Q1	–	Sell	-30,487	Closed	-$3.38M	–	192
2022 Q4	$3.38M	Sell	30,487 -501	-2%	-$51.2K	1.43%	10
2022 Q3	$2.67M	Sell	30,988 -370	-1%	-$33K	1.23%	16
2022 Q2	$2.86M	Buy	+31,358	New	+$2.78M	1.23%	13
2021 Q2	–	Sell	-4,495	Closed	-$331K	–	164
2021 Q1	$331K	Buy	4,495 +539	+14%	+$39.8K	0.13%	135
2020 Q4	$309K	Buy	3,956 +61	+2%	+$4.67K	0.13%	138
2020 Q3	$308K	Buy	3,895 +27	+0.7%	+$2.12K	0.14%	139
2020 Q2	$285K	Sell	3,868 -860	-18%	-$64.7K	0.14%	139
2020 Q1	$347K	Buy	4,728 +1,166	+33%	+$91.6K	0.19%	118
2019 Q4	$309K	Buy	+3,562	New	+$293K	0.13%	137

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wakefield Asset Management's MRK Position: Q2 2026 in Review

Wakefield Asset Management held its Merck (MRK) position steady in Q2 2026 at 8,331 shares worth $1.07M. The position accounts for 0.24% of the portfolio, ranked #134.

Wakefield Asset Management first reported a position in MRK in Q4 2019 and has held it in 15 quarters since. The position peaked at $3.38M in Q4 2022. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Wakefield Asset Management held 8,331 shares of Merck worth $1.07M as of Q2 2026.
Wakefield Asset Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.24% of Wakefield Asset Management's portfolio in Q2 2026, its #134 holding.
Wakefield Asset Management first reported a position in Merck in Q4 2019 and has held it in 15 quarters since.
Wakefield Asset Management's Merck position peaked at $3.38M in Q4 2022.
3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.